BridgeMD
Compares treatment options for Mandibular Atrophy
Official title Three-Dimensional Bone Augmentation of Severely Atrophied Posterior Mandibular Alveolar Ridges Using Customized-3D Zirconia Barriers Versus Pre-bent Titanium Mesh
ClinicalTrials.gov ID: NCT07700095
What this study is testing
- What it's testing
- Zirconia can be considered as an alternative and innovative material suitable for GBR because it has high biocompatibility, together with a scarce tissue integration. Zirconia barriers could be a predictable and alternative barrier material for GBR in terms of (i) biocompatibility, (ii) ease of use and removal, (iii) exposure management, (iv) bone regeneration outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50
You may be able to join if
- Patients are systemically medically free according to the American Society of Anesthesiologists (ASA) considered as ASA I.
- Ability to maintain good oral hygiene as evidenced in recall visits.
- patients who had a partial or completely edentulous alveolar ridge with apparent 3D defect following teeth loss.
- All patients were free from any local or general disease that may interfere with bone healing and had no history of previous grafting procedure at...
- The ridge had to exhibit severe vertical and horizontal (3D) alveolar ridge deficiency with alveolar ridge height less than 7 mm from the alveolar...
You likely can't join if
- Smoker (\> 25 cigarettes/ day).
- Patients undergoing radiotherapy or chemotherapy
- Patients having infection or local lesions in the area of surgery.
- Patients with diabetes mellitus or bone diseases which may compromise the results.
- Patient with poor oral hygiene or active periodontal disease.
- Patient with limited mouth opening.
See the full eligibility criteria
- Patients are systemically medically free according to the American Society of Anesthesiologists (ASA) considered as ASA I.
- Ability to maintain good oral hygiene as evidenced in recall visits.
- patients who had a partial or completely edentulous alveolar ridge with apparent 3D defect following teeth loss.
- All patients were free from any local or general disease that may interfere with bone healing and had no history of previous grafting procedure at the designated edentulous ridge.
- The ridge had to exhibit severe vertical and horizontal (3D) alveolar ridge deficiency with alveolar ridge height less than 7 mm from the alveolar crest to the inferior alveolar canal and width less than 5 mm which was...
- Pre-operative clinical assessment of soft tissue coverage was done to cover the graft and its membrane, in addition to assessment of occlusion and inter-arch distance should allow for the graft, membrane, implan and the...
- Smoker (\> 25 cigarettes/ day).
- Patients undergoing radiotherapy or chemotherapy
- Patients having infection or local lesions in the area of surgery.
- Patients with diabetes mellitus or bone diseases which may compromise the results.
- Patient with poor oral hygiene or active periodontal disease.
- Patient with limited mouth opening.
- Participation in other clinical trials
The study team makes the final eligibility decision.
Where it's taking place
- Kafr Elsheikh, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kafr Elsheikh, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.